News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,491 Results
Type
Article (88191)
Company Profile (825)
Press Release (784455)
Multimedia
Podcasts (207)
Webinars (32)
Section
Business (233353)
Career Advice (4152)
Deals (39897)
Drug Delivery (156)
Drug Development (91479)
Employer Resources (205)
FDA (18438)
Job Trends (17441)
News (398136)
Policy (39997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (165)
Alliances (56982)
ALS (191)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (379)
Approvals (18640)
Artificial intelligence (684)
Autoimmune disease (200)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (491)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (695)
Cancer (5353)
Cardiovascular disease (474)
Career advice (3579)
Career pathing (43)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (877)
Cervical cancer (40)
Clinical research (77429)
Collaboration (1962)
Company closure (6)
Compensation (1238)
Complete response letters (82)
COVID-19 (3005)
CRISPR (110)
C-suite (970)
Cystic fibrosis (157)
Data (6702)
Decentralized trials (2)
Denatured (76)
Depression (163)
Diabetes (556)
Diagnostics (7330)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (332)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100759)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135895)
Executive appointments (1072)
FDA (21817)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1652)
Gene editing (234)
Generative AI (71)
Gene therapy (722)
GLP-1 (1170)
Government (5484)
Grass and pollen (8)
Guidances (389)
Healthcare (20983)
HIV (76)
Huntington's disease (54)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (76)
Indications (134)
Infectious disease (3323)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (99)
Layoffs (663)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (20)
Lung cancer (717)
Lymphoma (396)
Machine learning (49)
Management (66)
Manufacturing (929)
MASH (184)
Medical device (15096)
Medtech (15162)
Mergers & acquisitions (23044)
Metabolic disorders (1484)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (386)
Neuropsychiatric disorders (108)
Neuroscience (3251)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (725)
Opinion (349)
Ovarian cancer (176)
Pain (232)
Pancreatic cancer (253)
Parkinson's disease (317)
Partnered (39)
Patents (548)
Patient recruitment (555)
Peanut (65)
People (67165)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23923)
Phase 2 (33596)
Phase 3 (25314)
Pipeline (6144)
Policy (358)
Postmarket research (3554)
Preclinical (10727)
Press Release (72)
Prostate cancer (273)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1022)
Real estate (7445)
Recruiting (81)
Regulatory (29366)
Reports (69)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (278)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (119)
Tariffs (101)
The Weekly (129)
Vaccines (1193)
Venture capital (103)
Weight loss (496)
Women's health (105)
Worklife (23)
Date
Today (161)
Last 7 days (898)
Last 30 days (3265)
Last 365 days (32870)
2026 (5804)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51700)
Australia (9085)
California (12232)
Canada (3477)
China (1234)
Colorado (517)
Connecticut (534)
Delaware (363)
Europe (118973)
Florida (1815)
Georgia (397)
Hawaii (4)
Idaho (68)
Illinois (1022)
India (81)
Indiana (574)
Iowa (24)
Japan (470)
Kansas (135)
Kentucky (49)
Louisiana (35)
Maine (84)
Maryland (1521)
Massachusetts (8977)
Michigan (381)
Minnesota (687)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (134)
New Hampshire (88)
New Jersey (3284)
New Mexico (33)
New York (3219)
North Carolina (1689)
North Dakota (10)
Northern California (5916)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2434)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4741)
Tennessee (193)
Texas (1922)
United States (44004)
Utah (370)
Vermont (1)
Virginia (308)
Washington D.C. (88)
Washington State (1012)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
There are 873,491 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. secure public reimbursement of ABILIFY ASIMTUFII®
March 4, 2026
·
6 min read
Press Releases
Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026
March 4, 2026
·
1 min read
Press Releases
Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples
March 4, 2026
·
4 min read
Press Releases
First-in-Human Use of CereVasc® eShunt® System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes
March 4, 2026
·
4 min read
Press Releases
Antheia Secures Additional $9 Million in Expanded BioMaP-Consortium Project Agreement to Onshore Pharmaceutical Supply Chains
March 4, 2026
·
3 min read
Press Releases
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026
March 4, 2026
·
4 min read
Press Releases
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
March 4, 2026
·
13 min read
Podcast
UniQure’s Delay, REGENXBIO’s Rejection Explained, Sarepta’s Ingram Steps Down, More
UniQure and REGENXBIO are both dealing with FDA setbacks for their respective gene therapies, as regulatory experts question the FDA’s decision-making processes; CBER director Vinay Prasad is under probe for allegedly fostering a toxic workplace; Sarepta CEO Doug Ingram is stepping down after several years of tumult at the top of the muscular dystrophy–focused company; and Eli Lilly again tops Novo Nordisk in a weight loss trial.
March 4, 2026
·
1 min read
·
Heather McKenzie
Press Releases
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
March 4, 2026
·
1 min read
Press Releases
Tevogen Announces Reverse Stock Split
March 4, 2026
·
6 min read
1 of 87,350
Next
